搜索到 1000 条关于 m 영종키스방∪「macho2.com} 영종키스방 영종룸♪영종핸플 영종마사지 的文章

2012.09.19 2011中国国际健康睡眠产业展览会

包:A 国内企业(3M×3M)12800元/个标准展位。境外企业(3M×3M)$3000美元/个标准展位。B 供希望...:+86-10- 69552554傳真:+86-10- 69551747 E mail:hanlm5210@163.com

SUMO, Ubiquitin, UBL Proteins: Implications for Human Diseases

M D Anderson Cancer Center主办,第七届会议将来到中国上海,由上海交通大学医学院和美国德州大学M D Anderson 癌症研究中心
2015 ADA:达格列净治疗亚洲 T2DM 患者耐性良好

2015.06.01 2015 ADA:达格列净治疗亚洲 T2DM 患者耐性良好

(低 BMI 组:BMI<25 kg/m2,高 BMI 组 ≥25 kg/m2)。以下数据来自 8 个不超过 24 周的 IIb/III 期临床试验,受试...来自中南大学湘雅二医院的周智广教授将在第 75 届 ADA 科学年会作报告:达格列净在超重及非超重亚洲 2 型糖尿病人群中的安全性和有效性研究。达格列净是一种

2015.07.06 盆底超声、四维子宫输卵管超声造影学习班 暨上海—同济超声医师高级研修班

; 金医生 E-mail:shcsxxb@163.com 
NICE 2 型糖尿病指南修订稿再度引发「质疑」

2015.09.11 NICE 2 型糖尿病指南修订稿再度引发「质疑」

一些问题,例如指南指出:GLP-1 受体激动剂仅用于 BMI ≥ 35 kg/m2 的 T2DM 患者,这并不符合逻辑,特别是建立在 NICE 指南本身就把肥胖定义为 BMI ≥ 30 kg/m2 之上。O'Hare 教授认为合理的方案是:GLP-1 受体激动剂适用于 BMI ≥ 30 kg/m2 的欧洲白种人
ASCO2015:丁香园专访中山大学肿瘤医院吴沛宏教授

2015.06.08 ASCO2015:丁香园专访中山大学肿瘤医院吴沛宏教授

ccvideo中山大学附属肿瘤医院吴沛宏教授及其团队的研究细分 M1 鼻咽癌的 SMART 策略,入选本届大会的壁报单元。吴教授在接受丁香园专访时说,SMART 策略可用于鉴定转移性鼻咽癌(mNPC)有治愈机会的病人,需要更多的试验评估可行性,以及在靶标病人获得完全缓解的重要性。
吴沛宏教授接受专访

2015.05.31 吴沛宏教授接受专访

中山大学附属肿瘤医院吴沛宏教授及其团队的研究细分 M1 鼻咽癌的 SMART 策略,入选本届大会的壁报单元。吴教授在接受丁香园专访时说,SMART 策略可用于鉴定转移性鼻咽癌(mNPC)有治愈机会的病人,需要更多的试验评估可行性,以及在靶标病人获得完全缓解的重要性。

2012.12.24 美国儿童与青少年精神病学会(AACAP):精神药理学进展会议

InstituteGabrielle A. Carlson, M.D., ChairJanuary 25-26, 2013
膜性肾病的治疗迈入 PLA2R 时代

2018.06.28 膜性肾病的治疗迈入 PLA2R 时代

M 型磷脂酶 A2 受体(PLA2R)是原发性膜性肾病(MN)的主要靶抗原,约占 75%~80%。仅小部分原发性 MN 由其他抗原(如血小板反应蛋白 1 型结构域 7A)所致。检测肾活检标本中的 PLA2R 抗原和血清中的抗 PLA2R 抗体为大部分 MN 患者提供了更精确的命名。我们不再使用「特发性」或「原发性

2012.10.19 心血管超声检查规范化解读学习班

:pkusz-ultrasound@foxmail.com;(2)短信注册:13760310818(黄医生);(3)通信地址:深圳市福田区莲花路1120号,北京大学深圳医院超声影像科心血管...、58、6、71、79、316、323、324、365、370、M358、2号观光线路公交至北大医院站由正门进入;2、 乘111、15、222、328
明明皮肤完整   为什么评为 2 期压疮?

2017.03.30 明明皮肤完整 为什么评为 2 期压疮?

及减压),外层用 2 个 3M 透明贴加强固定以防止溃疡贴卷边脱落。见下图。视敷贴固定情况决定更换频率。经过上述处理后,伤口已愈合,可见右侧水泡痂皮已经脱落。3...晨交班,责任组长小龚报告护士长,15 床患者宋某尾骶部有 2 期压疮。组内的其它小伙伴觉得奇怪,该患者明明皮肤完整的,怎么就发生 2 期压疮了呢?让我们一起

2012.09.19 首届全国淋巴增生性疾病病理读片会

目Prof. M...) The importance of a good H&E-stained slide(2) Selected

2012.09.19 2010中国难治性高血压高峰论坛

,未带学分卡需交10元工本费。2.座位有限,请早注册保证座席3.如需预订酒店(自费)请下载酒店预订申请表请将此表传真至:北京生物技术...; 真:010-68331730论坛信箱:hypertension2010@163.com地 

2019.02.20 2019 全国食品行业质量管理与技术论坛

;展位规格:3m×2m 费用:15800 元人民币 注:1、参展费用包含两套会议餐券;2、统一配置:三面隔板、一块楣板(标注公司 logo...:www.fqmt-c.com地址:北京市昌平区立汤路 186 号龙德紫金大厦 4-1203 室十、议程草案  
综述:糖尿病治疗新选择SGLT2抑制剂

2015.04.09 综述:糖尿病治疗新选择SGLT2抑制剂

列净最常见的尿路感染和生殖器真菌感染副作用。另外,对肾小球滤过率(eGFR)<60 mL/min/1.73m2的患者应谨慎使用。SGLT2抑制剂的药理学和药...剂量坎格列净起始剂量100mg每天一次,早餐前服用。对于eGFR≥60mL/min/1.73m22型糖尿病患者,可以增加到300mg/天;若患者
2A型腓骨肌萎缩症(综述)

2014.08.26 2A型腓骨肌萎缩症(综述)

/s;轴突型(CMT2),MNCV>40m/s,中间型,MNCV在30-40m/s之间。另外CMT1型为常染色体显性遗传,而CMT2型可为常染色体显性、隐性遗传...A,在CMT4A、CMT2C、17CMT4C、18CMT4F与CMT4B1中均有报道。早发组研究显示,腓总神经MNCV最低值为36m/s,而正中神经最低值为为40m/s,这与

2012.09.19 【免注册费】上海分子流行病学与GWAS会议国际研讨会

分子流行病学再揭示人类复杂疾病遗传因素及其与环境因素相互作用发挥重要作用,为人类疾病的风险评估、预防和个性化治疗提供依据。全基因组关联分析(GWAS)为全面系统研究复杂疾病的遗传因素掀开了新的一页,为我们了解人类复杂疾病的发病机制提供了更多的线索。科学家已经在肥胖、糖尿病、冠心病、阿尔茨海默、乳腺癌、前列腺癌、肺癌、胃癌等一系列复杂疾病中进行了全基因组关联研究并找到疾病相关的易感基因,我国科学家也在银屑病、精神病和冠心病等方面开展了GWAS研究并取得成效。国家科技部最新公布了“常见重大疾病全基因组关联分析和药物基因组学研究”的863重点项目,吹响了我国大规模开展GWAS研究的号角。为了让更多的相关研究人员,特别是广大研究生了解GWAS的研究原理和方法,学会设计GWAS的研究和分析实验结果,同时在癌症领域分享海内外研究专家们的成功经验,并期待在GWAS方面进行交流合作,复旦大学和美国Van Andel 研究所将于2009年7月12-14日在上海联合举办上海分子流行病学与GWAS国际 研讨会, 期待各位同道免费参加,请有意者及时将回执返回联系邮箱。免注册费(食宿餐饮费用自理)。名额有限,报名从速!时间: 2009年7月12-14日
报到地点: 复旦大学卿云楼宾馆 上海市邯郸路220号,200433
会议地点: 复旦大学逸夫楼报告厅
联 系 人: 赵雪莹 高歌 联系电话: 021-55664495
回执邮箱: GWAS2009@gmail.com
BackgroundRecent success of genome-wide association studies (GWAS) in the U.S. and Europe has lead to the identification of a large number of genetic variants that are associated with disease risk and progression, including those for cancer and cardiovascular diseases. The discovery of these genetic markers not only improves our understanding of disease etiology, but also contributes significantly to risk prediction, early detection, and targeted treatment of diseases.Although GWAS have been used in Chinese populations to identify Chinese-specific risk-associated genetic variants for several common diseases such as breast cancer and psoriasis, many more GWAS are needed for various diseases. A better understanding of the importance of GWAS and a better knowledge of study design and data analysis of GWAS will further promote broad application of GWAS in China. This symposium which will cover genetic epidemiology and GWAS in China is organized to serve this purpose. We have invited a group of experts in this area from the U.S. and China to share their experience in GWAS, and we hope to foster an environment which will encourage an open discussion among all participants.
Objectives• To better understand the potential applications of GWAS
• To address practical issues in study design, implementation, and data analysis of GWAS
• To promote interaction and collaboration among researchers who are interested in GWAS
• To explore other important studies after GWAS: gene-environment interaction, risk prediction, and functional analyses
• To consider issues and implications related to genomic and personalize medicine
Organizing committeeThe organizing committee consists of four members:
Dr. Jianfeng Xu (Co-Chair)
Dr. Daru Lu (Co-Chair)
Dr. Li Jin (Co-Chair ,Advisor)
Dr. Qingyi Wei (Co-Chair, Advisor)
PresentationsSession I: Genetic epidemiology and GWAS of cancer
• Breast cancer in Chinese populations Xiao-ou Shu
• Genetic association studies of skin cancer Jiali Han
• Genetic variants in the MC1R gene and risk of cutaneous melanoma Qingyi Wei
• Genetic association studies of lung cancer in Chinese populations Daru Lu
Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao Zhou
Molecular epidemiology of stomach cancer Weimin YeSession II: Genetic epidemiology and GWAS of other diseases
• Genetic association studies of hypertension in Chinese populations Jiang He
• GWAS of Autoimmune Diseases (Psoriasis, etc.) in Chinese populations Wei Huang
Molecular epidemiology of diabetes in Chinese populations Weiping Jia
Molecular genetics study of hypertension in Chinese populations Dingliang Zhu
Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao ZhouSession III: Post-GWAS studies
• Genetic structure of Chinese population Li Jin
• High-throughput genotyping for GWAS and fine mapping studies Siqun Lilly Zheng
Molecular genetics study of neural tube defect Hongyan Wang
• Risk prediction using genetic variants in prostate cancer Jianfeng Xu
• Gene-environmental interaction in smoking related cancer Zuo-Feng Zhang
• Cancer Somatic Genomics Bin TehSession IV: Short presentations by participants and discussion
Registration时  间: 2009年7月12-14日
报到地点: 复旦大学卿云楼宾馆大厅 上海市邯郸路220号 (200433)
会议地点: 复旦大学逸夫楼报告厅
联 系 人: 赵雪莹,高歌 (Shanghai, China);Tamara Adams (U.S.)
联系电话: 21-55664495 (Shanghai, China);336-713-7532 (U.S.)
回执邮箱: GWAS2009@gmail.com (Shanghai, China);tsadams@wfubmc.edu (U.S.)
Invited speakers (alphabetic)• Jiali Han, Ph.D., is an Assistant Professor of Medicine at Harvard Medical School. His major research areas are:
• Genetic epidemiology of skin cancer and breast cancer
• Genome-wide association studies
• Gene-environment interaction• Jiang He, M.D. Ph.D., is a Professor and Chair of Epidemiology, Tulane University School of Public Health., U.S.A. His major research areas are:
• Genetic epidemiology of hypertension
• Gene-nutrition interaction of cardiovascular disease• Wei Huang, Ph.D., is a Professor and Executive Deputy Director of Chinese National Human Genome Center at Shanghai, China. Her major research areas are:
• Genetic susceptibility to autoimmune diseases, cardiovascular diseases and cancer.
• Genome-wide association studies
• Genetic variants and association study• Weiping Jia M.D., is a professor of endocrinology at Shanghai Institute of Diabetes, Shanghai No.6 People’s Hospital, Shanghai Jiaotong University, Her major research area is:
Molecular endocrinology and diabetes• Li Jin, Ph.D, is a Professor of Genetics and vice President of Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolism diseases
• Genetic markers for population genetics• Daru Lu, Ph.D, is a Professor of Genetics and Vice Dean of School of Life Sciences, Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolic disease• Xiao-ou Shu, M.D, Ph,D, is a Professor of Medicine in the Department of Medicine at the Vanderbilt University School of Medicine, U.S.A. Her major research areas are:
• Genetic and lifestyle predictors of cancer and other chronic diseases
• Cohort study methodology
• Incorporating biomarkers in risk prediction• Bin Teh, M.D, is a Distinguished Scientific Investigator at Van Andel Institute, U.S.A. His major research areas are:
• Translational cancer research
• Gene expression profiling
• Cancer genome high-throughput sequencing• Hongyan Wang, Ph.D, is a professor of genetics at School of Life sciences, Fudan University, China. Her major research area is:
Molecular genetics and epidemiology of birth defects (deformity of neural tube, congenital heart disease, etc.)• Qingyi Wei, M.D, Ph.D, is a Professor of Epidemiology at The University of Texas M. D. Anderson Cancer Center, U.S.A. His major research areas are:
Molecular epidemiology of DNA repair, apoptosis, and skin cancer and head and neck cancer
• Genetic susceptibility to cancer
• DNA repair and apoptosis phenotype markers• Jianfeng Xu, M.D, Dr.PH, is a Professor of Epidemiology and Cancer Biology and Director of the Center for Cancer Genomics at Wake Forest University School of Medicine, U.S.A. His major research areas are:
• Genetic epidemiology of prostate cancer
• Genome-wide association and fine mapping analysis
• Risk prediction using genetic markers and other clinicopathologic variables• Zuo-Feng Zhang, M.D., Ph.D, is a Professor of Epidemiology at UCLA School of Public Health, U.S.A. His major research areas are:
Molecular epidemiology of smoking-related cancers
• Confirmation studies of SNPs identified in genome-wide association studies in smoking-related cancers
• Gene-environmental interaction between genetic markers and environmental factors• S. Lilly Zheng, M.D, is a Professor of Medicine and Director of the Genotyping Laboratory at Wake Forest University School of Medicine. U.S.A. Her major research areas are:
• High-throughput genotyping and sequencing
• Genetic epidemiology of prostate cancer• Gangqiao Zhou, Ph.D, is a Professor of Medical Genetics and Genomics in National Academy of Military Medical Science. His major research area is:
molecular and genetics of complex diseases• Dingliang Zhu, M.D, is a professor of cardiology at Shanghai Institute of Hypertension, Shanghai, China. His major research area is:
Molecular and genetics of cardiovascular diseases• Weimin Ye, Ph.D, is a Professor of Medical Epidemiology at Karolinska Institutet, Sweden. His major research areas are: Etiology of upper gastrointestinal diseases
• Topic of presentation: Molecular epidemiology of stomach cancer

2012.09.19 第八届全国抗菌药物临床药理学术会议

编:100029联 系 人:张 曼邮 箱:kathleen-m@126.com报名电话:010-82858897-106... 张 杰 张 忻 张秀珍 张婴元 赵彩芸 赵 立 赵志刚 郑 波学 术 内 容1. 抗菌药物作用机制研究/2. 细菌、真菌耐药机制研究/3.

2012.09.19 2011中国健康产业博览会及健康产业市长论坛

:中国市长协会 中国食文化研究会 上海市农学会 华港国际展览集团承办单位: 上海领行展览服务有限公司前 言:2010年9月2日至4...展馆和专业会展服务收费标准△、标准展位:(3m×3m) 价格:△、国际区域9800元/9㎡ 国内区域 8800元/9
上一页 1 2 3 ... 45 46 47 48 49 50 下一页 到第